MedTrace Logo

Effects of Leptin Treatment on Weight Loss

NCT00050791 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-10-19

No results posted yet for this study

Summary

This is a double blind placebo controlled clinical study designed to determine the effects of leptin on the changes that occur in the body during weight loss achieved by a very low calorie diet.

Conditions

Interventions

DRUG

Leptin

Leptin is an adipocyte hormone that functions as an afferent signal in a feedback loop regulating body weight

BEHAVIORAL

Very Low Calorie Diet

placebo injections

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    collaborator OTHER

  • St. Luke's-Roosevelt Hospital Center

    collaborator OTHER

  • Columbia University

    collaborator OTHER

  • Rockefeller University

    lead OTHER

Principal Investigators

  • Jeffrey Friedman, MD, PHD · Rockefeller University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-03-31
Primary Completion
2006-11-30
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00050791 on ClinicalTrials.gov